Basic fibroblast growth factor up-regulates the surface expression of complement receptors on human monocytes

Inflammation Research

Volumn 50, Issue 5, 2001, Pages 270-274

  Ohsaka, A ^a   Takagi, S ^b   Takeda, A ^b   Katsura, Y ^b   Takahashi, K ^b   Matsuoka, T ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ibaraki pref   (Japan)

Author keywords

Basic fibroblast growth factor; Complement receptors; Human monocytes

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD14 ANTIGEN; COMPLEMENT RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MONOCYTE; RECEPTOR UPREGULATION;

ADULT; ANTICOAGULANTS; ANTIGENS, CD14; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; INDICATORS AND REAGENTS; MACROPHAGE-1 ANTIGEN; MONOCYTES; RECEPTORS, COMPLEMENT; UP-REGULATION;

EID: 0034996726     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050753     Document Type: Article

References (23)

1. [1] Allouche M. Basic fibroblast growth factor and hematopoiesis. Leukemia 1995; 9: 937-42.
2. [2] Slack JMW, Darlington BG, Heath JK, Godsave SF. Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature 1987; 326: 197-200.
3. [3] Wilson EL, Rifkin DB, Kelly F, Hannocks M-J, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 1991; 77: 954-60.
4. [4] Bikfalvi A, Han ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992; 80: 1905-13.
5. [5] Takagi S, Takahashi K, Katsura Y, Matsuoka T, Ohsaka A. Basic fibroblast growth factor modulates the surface expression of effector cell molecules and primes respiratory burst activity in human neutrophils. Acta Haematol 2000; 103: 78-83.
6. [6] Ohsaka A, Saionji K, Kuwaki T, Takeshima T, Igari J. Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br J Haematol 1995; 89: 465-72.
7. [7] Lundahl J, Hallden G, Hallgren M, Skold CM, Hed J. Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures. J Immunol Methods 1995; 180: 93-100.
8. [8] Ziegler-Heitbrock HWL. Definition of human blood monocytes. J Leukocyte Biol 2000; 67: 603-6.
9. [9] Todd III RF, Nadler LM, Schlossman SF. Antigens on human monocytes identified by monoclonal antibodies. J Immunol 1981; 126: 1435-42.
10. [10] Cook J, Fischer E, Boucheix C, Mirsrahi M, Jouvin M-H, Weiss L et al. Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol 1985; 22: 531-9.
11. [11] Blondin C, Dur AL, Cholley B, Caroff M, Haeffner-Cavaillon N. Binding of lipopolysaccharide through soluble CD14 and membrane-bound CD14 pathways triggers cellular activation via a common transducing molecule. In: Kishimoto T, Kikutani H, von dem Borne AEGKr, Goyert SM, Mason DY, Miyasaka M et al. editors. Leucocyte Typing VI. New York and London: Garland Publishing, 1997: 965-8.
12. [12] Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 1987; 80: 535-44.
13. [13] Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75: 1037-50.
14. [14] Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
15. [15] Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-8.
16. [16] Bikfalvi A, Han ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992; 80: 1905-13.
17. [17] Allouche M, Bayard F, Clamens S, Fillola G, Sie P, Amalric F. Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells, Leukemia 1995; 9: 77-86.
18. [18] Hackshaw KV, Shi Y. Fibroblast growth factors mobilize peritoneal macrophage intracellular calcium. Life Sci 1994; 54: 661-70.
19. [19] Landriscina M, Cassano A, Ratto C, Longo R, Ippoliti M, Palazzotti B et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 1998; 78: 765-70.
20. [20] Martyre M-C, Le Bousse-Kerdiles M-C, Romquin N, Chevillard S, Praloran V, Demory J-L et al. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 1997; 97: 441-8.
21. [21] Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. Blood 1999; 94: 3334-9.
22. [22] Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C et al. Serum basic fibroblast growth factor in pediatric Crohn's disease: implications for wound healing. Dig Dis Sci 1997; 42: 378-86.
23. [23] Vlodavsky I, Bashkin P, Ishai-Michaeli R, Chajek-Shaul T, Bar-Shavit R, Haimovitz-Friedman A et al. Sequestration and release of basic fibroblast growth factor. Ann NY Acad Sci 1991; 638: 207-20.